Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Thomas Callahan, IV, MD, is Staff Physician and Director of Inpatient Services in the Section of Pacing and Electrophysiology of the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is also the Associate Program Director for Cleveland Clinic’s cardiology and electrophysiology fellowships.
Specialty interests: Abnormal heart rhythm, atrial fibrillation, sudden cardiac death, supraventricular tachycardia, ventricular tachycardia, Wolff-Parkinson-White syndrome, biventricular pacemaker, catheter ablation, implantable cardiac defibrillator, lead extraction, radiofrequency ablation
Number of Procedures Performed: Dr. Callahan has performed more than 700 catheter ablation procedures throughout his career.
Success rates: Cleveland Clinic has been ranked the #1 hospital for cardiology and heart surgery by U.S. News & World Report since 1994. Success rates for specific procedures are available at http://my.clevelandclinic.org/heart/about-heart-vascular-institute/treatment-outcomes.aspx
Education and Training: Dr. Callahan received his undergraduate degree from Oberlin College, OH. He received his master's degree from the University of Michigan, and he earned his medical degree from Eastern Virginia Medical School, Norfolk. He joined Cleveland Clinic in 2003 and completed fellowships in Cardiovascular Medicine Cardiac Electrophysiology and Pacing. Prior to coming to Cleveland Clinic, he was a resident at the Hospital of the University of Pennsylvania, where he was Chief Resident in internal medicine.
Publications and Speaking: Dr. Callahan has authored and co-authored many articles published in leading medical journals.
About Dr. Callahan: “I enjoy my field because we have the ability to make many patients feel dramatically better. I am also excited by the constant advancement in the field.”
Leisure Activities: Dr. Callahan is a private pilot. He also enjoys skiing and spending time with his family.
Abnormal heart rhythm, atrial fibrillation, sudden cardiac death, supraventricular tachycardia, ventricular tachycardia, Wolff-Parkinson-White syndrome, biventricular pacemaker, catheter ablation, implantable cardiac defibrillator, lead extraction, radiofrequency ablation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/13/2015, Dr. Callahan, IV has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.